The U.S. Supreme Court ruled on May 16, 2024 that state courts cannot hold Bayer liable for failing to warn consumers about cancer risks associated with its Roundup weedkiller. The justices overturned a jury verdict in Missouri that awarded $1.25 million to John Durnell, who claimed non-Hodgkin's lymphoma from exposure to glyphosate, the active ingredient in Roundup.
Key Takeaways
The U.S. Supreme Court ruled that state courts cannot hold Bayer liable for failing to warn consumers about cancer risks from its Roundup weedkiller on May 16, 2024. The decision is expected to block thousands of lawsuits nationwide.
- Supreme Court rules in a 7-2 decision on May 16, 2024 that Bayer cannot be sued over state-level claims about cancer risks from Roundup weedkiller
- Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state-level failure-to-warn claims according to the Court's majority opinion written by Justice Brett Kavanaugh
- The ruling is expected to block thousands of similar lawsuits nationwide
- Bayer plans to proceed with a proposed $7.25 billion class-action settlement intended to resolve many of the remaining claims
Source Claims Check
1 Difference Found| Claim | Status | Reason | |
|---|---|---|---|
| Case Background | 1 Difference | Reuters reports on jury verdict, PBS and Los Angeles Times report on settlement | ▼ |
| Ruling Date | Broad Agreement | May 16, 2024 ruling date | |
| Ruling Outcome | Broad Agreement | 7-2 decision in favor of Bayer | |
| Federal Law Preemption | Broad Agreement | FIFRA preempts state-level failure-to-warn claims. |
The Court agreed with Bayer that federal law governing pesticides precludes failure-to-warn claims brought under state law. The ruling is expected to block thousands of similar lawsuits nationwide. President Donald Trump's administration backed Bayer in the case.
Bayer acquired Roundup as part of its $63 billion purchase of agrochemical company Monsanto in 2018. The German drugmaking and crop science company had faced over 100,000 lawsuits alleging a cancer link from glyphosate exposure. Bayer said the lawsuits threatened its ability to supply Roundup to farmers.
The Supreme Court's decision centers on the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), which governs pesticide labeling and bars states from imposing differing or additional requirements. The EPA has repeatedly approved labels without a cancer warning, demonstrating that these products are not misbranded.
Environmental activists criticized the ruling, with Tarah Heinzen of Food and Water Watch calling it a disaster for public health. Kelly Ryerson, co-executive director of American Regeneration and an activist known as 'The Glyphosate Girl,' warned that the decision would perpetuate chronic disease epidemics.
Bayer had previously announced a proposed $7.25 billion settlement to resolve tens of thousands of current and future lawsuits, though this does not affect claims from pending appeals or those outside the deal. The ruling is seen as a victory for Bayer but has sparked political tensions within Trump's 'Make America Healthy Again' movement.
How this summary was created
This summary synthesizes reporting from 8 independent publishers using AI. All sources are cited and linked below. NewsBalance is a news aggregator and media literacy tool, not a news publisher. AI-generated content may contain errors or inaccuracies — always verify important information with the original sources.
